Delayed embryonic development or a long sperm survival in two mares-A registration conundrum.

Equine Vet J. January 2024;56(1):131 - 136.

Patrick M McCue¹, Philip M Matthews², Melissa J Prell³, Rebecca R Bellone⁴, Heather Allen⁵

¹ Equine Reproduction Laboratory, Colorado State University, Fort Collins, Colorado, USA.; ² Peterson Smith Advanced Fertility Center, Peterson & Smith Equine Hospital, Ocala, Florida, USA.; ³ Peterson Smith Advanced Fertility Center, Peterson & Smith Equine Hospital, Ocala, Florida, USA.; ⁴ Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California, Davis, California, USA.; ⁵ Bureau Veritas Laboratories, Guelph, Ontario, Canada.

Abstract

BACKGROUND:Genetic testing is required for the registration of foals of most equine breeds.

OBJECTIVES:To describe two clinical cases of marked delayed embryonic development or delayed fertilisation in pregnancies generated by embryo transfer.

STUDY DESIGN:Case report.

METHODS:Donor mares were inseminated with semen from one stallion during one oestrous cycle and semen from a different stallion on the subsequent oestrous cycle. Embryo(s) were collected 8 days after ovulation during the second oestrous cycle and transferred into synchronised recipient mares. Genetic testing was performed to determine parentage of the two foals.

RESULTS:For both foals, DNA parentage testing excluded the second stallion as the genetic sire and confirmed that the first stallion, whose semen was inseminated on the previous oestrous cycle, was the actual genetic sire.

MAIN LIMITATIONS:Rare event in horses; two clinical cases are described.

CONCLUSIONS:It is hypothesised that either marked delayed embryonic development or extended sperm survival occurred in the donor mares. Without genetic testing, parentage assignment based solely on breeding records would have been incorrect.

Keywords

DNA; delayed; embryonic development; horse; parentage;

Article Tools:

Medline

Email to me

Archives Highlights:

Trust in veterinarians and association with vaccine information sources and vaccination status among dog and cat owners.
62.9% of dog and 61.2% of cat owners were classified as trusting their veterinarians. On average, dog owners consulted 2.50 sources about vaccine information; cat owners consulted 2.27 sources. Veterinarians were the most common primary sources of information for 85.4% of dog owners with high levels of trust, but only 62.6% of dog owners with lower levels. This was the case for 83.8% and 56.3% of cat owners.

Retrospective cohort study on diseases and risk factors associated with death in hospitalized neonatal foals.
Most prevalent diseases were sepsis (43.9%), enteritis (14.0%), and omphalitis (9.0%). Case fatality rate was 33.3%. Neonatal sepsis significantly increased the risk of death.

Duration of efficacy and effect of implant location in adult queens treated with a 9.4 mg deslorelin subcutaneous implant.
The average duration of action of the 9.4 mg deslorelin implant was 790 ± 155 days (range 525-1140 days) with no significant difference in duration or efficacy depending on implantation sites. The 9.4 mg deslorelin implant causes pharmacological sterilization for about 2 years in female cats, is fully reversible, and caused no clinically relevant side effects when administered at both interscapular and periumbilical sites.

Effects of intranasal maropitant on clinical signs of naturally acquired upper respiratory disease in shelter cats.
There was no significant difference in clinical improvement score between the maropitant treatment and control groups for conjunctivitis, blepharospasm, ocular discharge, nasal discharge, or total disease severity after 7 days.

Feline blood donation: Description and adverse reactions from 29 201 donation events between 2019 and 2023.
Adverse reactions were uncommon (0.29%, 2.88/1000 donor events) and most commonly were cardiorespiratory (0.08%, 0.75/1000 donor events) or behavioral (0.06%, 0.62/1000 donor events). The only risk factor significantly associated with adverse reactions was conscious donation, with conscious donors 4.4 times more likely to have an adverse reaction.